Skip to main content
Log in

Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study

  • Cardiac
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

Dipyridamole stress cardiac magnetic resonance (CMR) evaluates the key phases (perfusion and wall motion) of the ischemic cascade. We sought to determine the prognostic value of dipyridamole stress-CMR in consecutive patients symptomatic for chest pain.

Methods

Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days. Patients were classified in group 1 (no- reversible ischemia), group 2 (stress perfusion defect alone), and group 3 [stress perfusion defect plus abnormal wall motion (AWM)]. End points were "all cardiac events" (myocardial infarction, cardiac death and revascularization) and "hard cardiac events" (all cardiac events excluding revascularization).

Results

One hundred and ninety-five (24 %) all cardiac events and 53 (7 %) hard cardiac events were observed. All and hard cardiac event rates in groups 1, 2, and 3 were 11 %, 49 %, 69 % and 4 %, 8 %, 21 %, respectively, with a higher rate in group 2 vs. group 1 (p<0.01) and group 3 vs. groups 1 and 2 (p<0.01). Multivariate analysis showed the presence of late gadolinium enhancement and stress perfusion defect plus AWM as independent predictors of all and hard cardiac events.

Conclusions

Dipyridamole stress-CMR improves prognostic stratification of patients through differentiation between the different components of the ischemic cascade.

Key Points

Dipyridamole stress cardiac magnetic resonance helps to assess coronary artery disease.

Novel technique to study the key phases of myocardial ischemia.

Combined assessment of perfusion and motion defects.

Dipyridamole stress imaging has additional value for predicting cardiac events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AWM:

abnormal wall motion

CAD:

coronary artery disease

CMR:

cardiac magnetic resonance

ECG:

electrocardiogram

ICA:

invasive coronary angiography

LGE:

late gadolinium enhancement

SD:

standard deviation

SPECT:

single photon emission computed tomography

References

  1. Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, Hayes SW, Hartigan PM et al (2008) COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283–1291

    Article  PubMed  Google Scholar 

  2. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480–489

    Article  PubMed  Google Scholar 

  4. Greenwood JP, Motwani M, Maredia N, Brown JM, Everett CC, Nixon J et al (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460

    Article  PubMed  PubMed Central  Google Scholar 

  5. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K et al (2013) MR-IMPACT. Investigators. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 34:775–781

    Article  PubMed  Google Scholar 

  6. Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M (2013) Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol 62:826–838

    Article  PubMed  Google Scholar 

  7. Pontone G, Andreini D, Bartorelli AL, Bertella E, Cortinovis S, Mushtaq et al (2013) A long-term prognostic value of CT angiography and exercise ECG in patients with suspected CAD. JACC Cardiovasc Imaging 6:641–650

    Article  PubMed  Google Scholar 

  8. Kramer CM, Barkhausen J, Flamm SD, Raymond JK, Nagel E (2008) Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 10:35

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al (2006) Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113:2733–2743

    Article  PubMed  Google Scholar 

  10. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L et al (2008) Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 10:18

    Article  PubMed  PubMed Central  Google Scholar 

  11. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 50:1343–1353

    Article  PubMed  Google Scholar 

  12. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E et al (1999) Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99:763–770

    Article  CAS  PubMed  Google Scholar 

  13. Macwar RR, Williams BA, Shirani J (2013) Prognostic value of adenosine cardiac magnetic resonance imaging in patients presenting with chest pain. Am J Cardiol 112:46–50

    Article  PubMed  Google Scholar 

  14. Buckert D, Dewes P, Walcher T, Rottbauer W, Bernhardt P (2013) Intermediate-term Prognostic value of reversible perfusion deficit diagnosed by adenosine CMR: a prospective follow-up study in a consecutive patient population. JACC Cardiovasc Imaging 6:56–63

    Article  PubMed  Google Scholar 

  15. Coelho-Filho OR, Seabra LF, Mongeon FP, Abdullah SM, Francis SA, Blankstein R et al (2011) Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging 4:850–861

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kelle S, Chiribiri A, Vierecke J, Egnell C, Hamdan A, Jahnke C et al (2011) Long-term prognostic value of dobutamine stress CMR. JACC Cardiovasc Imaging 4:161–172

    Article  PubMed  Google Scholar 

  17. Wallace EL, Morgan TM, Walsh TF, Dall’Armellina E, Ntim W, Hamilton CA et al (2009) Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging 2:299–307

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV et al (2007) Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 50:1174–1179

    Article  PubMed  Google Scholar 

  19. Bodí V, Rumiz E, Merlos P, Nunez J, Lopez-Lereu MP, Monmeneu JV et al (2011) One-week and 6-month cardiovascular magnetic resonance outcome of the pharmacoinvasive strategy and primary angioplasty for the reperfusion of ST-segment elevation myocardial infarction. Rev Esp Cardiol 64:111–120

    Article  PubMed  Google Scholar 

  20. Elhendy A, Geleijnse ML, Roelandt JR, van Domburg RT, TenCate FJ, Comel JH et al (1996) Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol 27:323–329

    Article  CAS  PubMed  Google Scholar 

  21. Nasis A, Ko BS, Leung MC, Antonis PR et al (2013) Diagnostic accuracy of combined coronary angiography and adenosine stress myocardial perfusion imaging using 320-detector computed tomography: pilot study. Eur Radiol 23:1812–1821

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Gianluca Pontone. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. Fabrizio Veglia kindly provided statistical advice for this manuscript.

One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. No study subjects or cohorts have been previously reported. Methodology: retrospective, diagnostic and prognostic study, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianluca Pontone.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pontone, G., Andreini, D., Bertella, E. et al. Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. Eur Radiol 26, 2155–2165 (2016). https://doi.org/10.1007/s00330-015-4064-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-4064-x

Keywords

Navigation